{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:41:52Z","timestamp":1780393312795,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.amjcard.2020.12.037","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T18:32:01Z","timestamp":1609957921000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Comparison of the Efficacy and Safety of Sacubitril\/Valsartan versus Ramipril in Patients With ST-Segment Elevation Myocardial Infarction"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9875-7519","authenticated-orcid":false,"given":"Ahmed","family":"Rezq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2528-0155","authenticated-orcid":false,"given":"Mostafa","family":"El Nozahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2020.12.037_bib0001","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199911043411901","article-title":"Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction","volume":"341","author":"Zijlstra","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0003","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/eurheartj\/ehi138","article-title":"Task force for percutaneous coronary interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology","volume":"26","author":"Silber","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0004","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1053\/euhj.2001.3035","article-title":"Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction","volume":"23","author":"Henriques","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jacc.2004.03.058","article-title":"Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb\/IIIa inhibition, in acute myocardial infarction","volume":"44","author":"Costantini","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0006","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0007","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1161\/CIRCULATIONAHA.117.027773","article-title":"Scope of sacubitril\/valsartan eligibility after heart failure hospitalization: findings from the GWTG-HF registry (get with the guidelines-heart failure)","volume":"135","author":"Parikh","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0008","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0009","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jacc.2019.08.001","article-title":"2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"74","author":"Hollenberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0010","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/ejhf.1531","article-title":"Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the heart failure association of the European Society of Cardiology","volume":"21","author":"Seferovic","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0011","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","volume":"66","author":"Hicks","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0013","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.CIR.81.4.1161","article-title":"Ventricular remodeling after myocardial infarction: experimental observations and clinical implications","volume":"81","author":"Pfeffer","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0014","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0735-1097(93)90042-Y","article-title":"Activation of neurohumoral systems in postinfarction left ventricular dysfunction","volume":"22","author":"Rouleau","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0016","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative North Scandinavian Enalapril survival study (CONSENSUS)","volume":"316","author":"Swedberg","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0017","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0018","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0019","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1073\/pnas.86.19.7580","article-title":"Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan","volume":"86","author":"Gros","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(89)90714-9","article-title":"Effects of UK 69 578: a novel atriopeptidase inhibitor","volume":"334","author":"Northridge","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0021","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/01.RES.71.6.1501","article-title":"Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers","volume":"71","author":"Richards","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0022","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/1755-5922.12053","article-title":"Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat","volume":"32","author":"Dalzell","year":"2014","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0023","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.CIR.97.23.2323","article-title":"Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo","volume":"97","author":"Ferro","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.12.037_bib0024","unstructured":"Prospective ARNI vs ACE inhibitor trial to determIne superiority in reducing heart failure events after MI - full text view - clinicaltrials.gov. Accessed March 31, 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02924727"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920313655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920313655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:36:17Z","timestamp":1757572577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914920313655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":24,"alternative-id":["S0002914920313655"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.12.037","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Efficacy and Safety of Sacubitril\/Valsartan versus Ramipril in Patients With ST-Segment Elevation Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.12.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}